| HOME >> BIOLOGY >> TECHNOLOGY |
Goals for 2008
During the balance of 2008, WaferGen will continue to work toward the
creation of corporate and shareholder value through the achievement of key
milestones, including:
-- Completion of SmartChip(TM) alpha testing at University of Pittsburg
Medical School
-- Publication/presentation of SmartChip(TM) alpha test results
-- Establishment of strategic SmartChip(TM) collaborations with premier
academic/genomics centers
-- Continued expansion of SmartSlide(TM) worldwide distribution channels
-- Establishment of manufacturing and production in Malaysia
About WaferGen
WaferGen Biosystems Inc. is a leader in the development, manufacture
and sale of state-of-the-art systems for gene expression, genotyping, cell
biology and stem cell research for the life science and pharmaceutical
industries. The company is actively developing its SmartChip(TM) product
for the gene expression and genotyping markets. SmartChip is being
developed as the first whole genome, high throughput gene expression
real-time polymerase chain reaction (PCR) platform. This innovative system,
combined with next-generation chemistry and optimized assays being
developed by WaferGen, promises to deliver significant speed and cost
advantages to researchers in the gene expression and genotyping markets.
Based on collaborations established with leading research institutions,
WaferGen believes that the SmartChip Real-Time PCR System is positioned as
the platform of choice for biomarker discovery and validation. WaferGen
currently markets its SmartSlide(TM) family of products to companies and
organizations involved in stem cell and cell biology researc
'/>"/>
| SOURCE WaferGen Biosystems, Inc. Copyright©2008 PR Newswire. All rights reserved |